On the interaction of doxorubicin with oleate ions: Fluorescence spectroscopy and liquid-liquid extraction study

Chemical and Pharmaceutical Bulletin

Volumn 55, Issue 7, 2007, Pages 1006-1010

  Munnier, Emilie ^a,b,c   Tewes, Frédéric ^a,b   Cohen Jonathan, Simone ^a,b   Linassier, Claude ^c   Douziech Eyrolles, Laurence ^a,b   Marchais, Hervé ^a,b   Soucé, Martin ^a,b   Hervé, Katel ^a,b   Dubois, Pierre ^a,b   Chourpa, Igor ^a,b  

^a UNIVERSITÉ DE TOURS   (France)

^b IFR 135   (France)

^c CHU BRETONNEAU   (France)

Author keywords

Doxorubicin; Fluorescence spectroscopy; Oleate

Indexed keywords

DICHLOROMETHANE; DOXORUBICIN; OLEATE SODIUM;

AQUEOUS SOLUTION; ARTICLE; CHEMICAL INTERACTION; ELECTRICITY; FLUORESCENCE SPECTROSCOPY; HYDROPHOBICITY; LIPOPHILICITY; LIQUID LIQUID EXTRACTION; PARTITION COEFFICIENT; PH MEASUREMENT;

ANTIBIOTICS, ANTINEOPLASTIC; CATIONS; DOXORUBICIN; HYDROGEN-ION CONCENTRATION; LIPIDS; MODELS, BIOLOGICAL; MOLECULAR STRUCTURE; OLEIC ACID; SOLUBILITY; SPECTROMETRY, FLUORESCENCE; WATER;

EID: 34347369996     PISSN: 00092363     EISSN: 13475223     Source Type: Journal    
DOI: 10.1248/cpb.55.1006     Document Type: Article

References (25)

1. Hoke E. M., Maylocka C. A., Shacterb E., Free Radic. Biol. Med., 39, 403-411 (2005).
2. Barraud L., Merle P., Soma E., Lefrançois L., Guerret S., Chevallier M., Dubernet C., Couvreur P., Trepo C., Vitvitski L., J. Hepatol., 42, 736-743 (2005).
3. Bradley G., Juranka P. F., Ling V., Biochim. Biophys. Acta, 944, 87-128 (1988).
4. Razzano G., Rizzo V., Vigevani A., IL Farmaco, 45, 215-222 (1990).
5. McLennan I. J., Lenkinski R. E., Yanuka Y., Can. J. Chem./Rev. Can. Chim., 63, 1233-1238 (1985).
6. Gallois L., Fiallo M., Laigle A., Priebe W., Garnier-Suillerot A., Eur. J. Biochem., 241, 879-887 (1996).
7. Zara G. P., Cavalli R., Fundaro A., Bargonic A., Caputob O., Gascob M. R., Pharmacol. Res., 40, 281-286 (1999).
8. Koufopoulou S. A., Pistos C., Giaginis C., Tsantili-Kakoulidou A., Int. J. Pharm., 316, 52-57 (2006).
9. Choi S. H., Park T. G., Int. J. Pharm., 203, 193-202 (2000).
10. Wang M. Y., Yang Y. Y., Heng P. W. S., Int. J. Pharm., 290, 25-36 (2005).
11. Menendez J. A., del Mar Barbacid M., Montero S., Sevilla E., Escrich E., Solanas M., Cortès-Funes H., Colomer R., Eur. J. Cancer, 37, 402-413 (2001).
12. Edwards K., Silvander M., Karlsson G., Langmuir, 11, 2429-2434 (1995).
13. Borné J., Nylander T., Khan A., Langmuir, 17, 7742-7751 (2001).
14. Borné J., Nylander T., Khan A., J. Colloid Interface Sci., 257, 310-320 (2003).
15. Rasi S., Mavelli F., Luisi P. L., Orig. Life Evol. Biosph., 34, 215-224 (2004).
16. Pietrzak M., Wieczorek Z., Stachelska A., Darzynkiewicz Z., Biophys. Chemist., 104, 305-313 (2003).
17. Szulawska A., Gniazdowski M., Czyz M., Biochem. Pharmacol., 69, 7-18 (2005).
18. Karukstis K. K., Thompson E. H. Z., Whiles J. A., Rosenfeld R. J., Biophys. Chemist., 73, 249-263 (1998).
19. Das K., Jain B., Dube A., Gupta P. K., Chem. Phys. Lett., 401, 185-188 (2005).
20. Hildebrand A., Garidel P., Neubert R., Blume A., Langmuir., 20, 320-328 (2004).
21. Gallois L., Fiallo M., Garnier-Suillerot A., Circular Dichroism Study, BBA-Biomembranes, 1370, 31-34 (1998).
22. Tewes F., Munnier E., Antoon B., Ngaboni Okassa L., Cohen-Jonathan S., Marchais H., Douziech-Eyrolles L., Soucé M., Dubois P., Chourpa I., Eur. J. Pharm. Biopharm. doi: 10.1016/j.ejpb.2007.02.016 (2007).
23. Beijnen J. H., van der Houwen O. A. G. J., Underberg W. J. M., Int. J. Pharm., 32, 123-131 (1986).
24. Germain E., Chajès V., Cognault S., Lhuillery C., Bougnoux P., Int. J. Cancer, 75, 578-583 (1998).
25. Wang Y., Li L., Jiang W., Yang Z., Zhang Z., Bioorg. Med. Chem. Lett., 16, 2974-2977 (2006).